Annual report pursuant to Section 13 and 15(d)

SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE (Details)

v3.22.0.1
SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE (Details) - shares
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Conversion of Series B Preferred Stock [Member]    
Antidilutive securities, shares 9,430,963 1,756,250
Common Stock Options [Member]    
Antidilutive securities, shares 1,112,619 468,619
Common Stock Warrants [Member]    
Antidilutive securities, shares 1,483,333 46,154
Conversion of Convertible Notes Not Inclusive of Accured Interest [Member]    
Antidilutive securities, shares 3,025,000  
Conversion of Debentures [Member]    
Antidilutive securities, shares 218,750 625,000
Conversion of Debentures [Member] | Shares May Be Converted into Bridge Notes [Member]    
Antidilutive securities, shares   6,578,702
Conversion of Redeemable Convertible Preferred Stock [Member]    
Antidilutive securities, shares 4,329,250 2,727,273
Conversion of series E preferred stock [Member].    
Antidilutive securities, shares   7,650,000